BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33620063)

  • 21. Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway.
    Li T; Zheng R; Xu L; Zhou M; Wang X; Guo Q; Ji H; Li L
    Toxicol Appl Pharmacol; 2020 Dec; 408():115248. PubMed ID: 32976922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice.
    Fan S; Liu C; Jiang Y; Gao Y; Chen Y; Fu K; Yao X; Huang M; Bi H
    J Ethnopharmacol; 2019 Dec; 245():112103. PubMed ID: 31336134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease.
    Blokker BA; Maijo M; Echeandia M; Galduroz M; Patterson AM; Ten A; Philo M; Schungel R; Gutierrez-de Juan V; Halilbasic E; Fuchs C; Le Gall G; Milkiewicz M; Milkiewicz P; Banales JM; Rushbrook SM; Mato JM; Trauner M; Müller M; Martínez-Chantar ML; Varela-Rey M; Beraza N
    Hepatology; 2019 Feb; 69(2):699-716. PubMed ID: 30229970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baicalein alleviates intrahepatic cholestasis by regulating bile acid metabolism via an FXR-dependent manner.
    Huang W; Qian Y; Lin J; Wang F; Kong X; Tan W
    Biochem Biophys Res Commun; 2024 Apr; 705():149670. PubMed ID: 38442444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formononetin ameliorates cholestasis by regulating hepatic SIRT1 and PPARα.
    Yang S; Wei L; Xia R; Liu L; Chen Y; Zhang W; Li Q; Feng K; Yu M; Zhang W; Qu J; Xu S; Mao J; Fan G; Ma C
    Biochem Biophys Res Commun; 2019 May; 512(4):770-778. PubMed ID: 30928103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-series metabolomics insights into the progressive characteristics of 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestatic liver fibrosis in mice.
    Li Y; Xue H; Fang S; Wang G; Wang Y; Wang T; Shi R; Wu J; Ma Y
    J Pharm Biomed Anal; 2021 May; 198():113986. PubMed ID: 33690095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice.
    Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Ommati MM; Abdoli N; Aghaei F; Esfandiari A; Azarpira N; Niknahad H
    Biomed Pharmacother; 2018 Jan; 97():1086-1095. PubMed ID: 29136945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatoprotection of auraptene from peels of citrus fruits against thioacetamide-induced hepatic fibrosis in mice by activating farnesoid X receptor.
    Gao X; Wang C; Ning C; Liu K; Wang X; Liu Z; Sun H; Ma X; Sun P; Meng Q
    Food Funct; 2018 May; 9(5):2684-2694. PubMed ID: 29721568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammalian Target of Rapamycin Complex 2 Signaling Is Required for Liver Regeneration in a Cholestatic Liver Injury Murine Model.
    Zhou Y; Xu M; Liu P; Liang B; Qian M; Wang H; Song X; Nyshadham P; Che L; Calvisi DF; Li F; Lin S; Chen X
    Am J Pathol; 2020 Jul; 190(7):1414-1426. PubMed ID: 32275903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress.
    Zhao SS; Li NR; Zhao WL; Liu H; Ge MX; Zhang YX; Zhao LY; You XF; He HW; Shao RG
    Acta Pharmacol Sin; 2018 Feb; 39(2):213-221. PubMed ID: 28748913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolomic analysis of cholestatic liver damage in mice.
    Yang R; Zhao Q; Hu DD; Xiao XR; Huang JF; Li F
    Food Chem Toxicol; 2018 Oct; 120():253-260. PubMed ID: 30009888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of CBP/β-catenin signaling ameliorated fibrosis in cholestatic liver disease.
    Kimura M; Nishikawa K; Osawa Y; Imamura J; Yamaji K; Harada K; Yatsuhashi H; Murata K; Miura K; Tanaka A; Kanto T; Kohara M; Kamisawa T; Kimura K
    Hepatol Commun; 2022 Oct; 6(10):2732-2747. PubMed ID: 35855613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined Inhibition of the TGF-β1/Smad Pathway by
    Shen Y; Jiang B; Zhang C; Wu Q; Li L; Jiang P
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvianolic acid B protects against ANIT-induced cholestatic liver injury through regulating bile acid transporters and enzymes, and NF-κB/IκB and MAPK pathways.
    Li S; Wang R; Wu B; Wang Y; Song F; Gu Y; Yuan Y
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1169-1180. PubMed ID: 31098695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Makisterone A attenuates experimental cholestasis by activating the farnesoid X receptor.
    Kang P; Li S
    Biochem Biophys Res Commun; 2022 Oct; 623():162-169. PubMed ID: 35921707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Melittin Treatment in Cholangitis and Biliary Fibrosis in a Model of Xenobiotic-Induced Cholestasis in Mice.
    Kim KH; Sung HJ; Lee WR; An HJ; Kim JY; Pak SC; Han SM; Park KK
    Toxins (Basel); 2015 Aug; 7(9):3372-87. PubMed ID: 26308055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity.
    Kong Y; Gao X; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Sun P; Meng Q
    Eur J Pharmacol; 2018 Apr; 824():64-71. PubMed ID: 29427579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics research on the hepatoprotective effect of cultured bear bile powder in α-naphthylisothiocyanate-induced cholestatic mice.
    Wu J; Fang S; Li W; Li Y; Li Y; Wang T; Yang L; Liu S; Wang Z; Ma Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1153():122269. PubMed ID: 32739790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tectorigenin alleviates intrahepatic cholestasis by inhibiting hepatic inflammation and bile accumulation via activation of PPARγ.
    Xiang J; Yang G; Ma C; Wei L; Wu H; Zhang W; Tao X; Jiang L; Liang Z; Kang L; Yang S
    Br J Pharmacol; 2021 Jun; 178(12):2443-2460. PubMed ID: 33661551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo.
    Zhang G; Sun X; Wen Y; Shi A; Zhang J; Wei Y; Wu X
    Eur J Pharmacol; 2020 Oct; 885():173498. PubMed ID: 32841642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.